Suppr超能文献

免疫介导的再生障碍性贫血患者淋巴细胞中的体细胞突变。

Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.

作者信息

Lundgren Sofie, Keränen Mikko A I, Kankainen Matti, Huuhtanen Jani, Walldin Gunilla, Kerr Cassandra M, Clemente Michael, Ebeling Freja, Rajala Hanna, Brück Oscar, Lähdesmäki Harri, Hannula Sari, Hannunen Tiina, Ellonen Pekka, Young Neal S, Ogawa Seishi, Maciejewski Jaroslaw P, Hellström-Lindberg Eva, Mustjoki Satu

机构信息

Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.

Translational Immunology Research program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.

出版信息

Leukemia. 2021 May;35(5):1365-1379. doi: 10.1038/s41375-021-01231-3. Epub 2021 Mar 30.

Abstract

The prevalence and functional impact of somatic mutations in nonleukemic T cells is not well characterized, although clonal T-cell expansions are common. In immune-mediated aplastic anemia (AA), cytotoxic T-cell expansions are shown to participate in disease pathogenesis. We investigated the mutation profiles of T cells in AA by a custom panel of 2533 genes. We sequenced CD4+ and CD8+ T cells of 24 AA patients and compared the results to 20 healthy controls and whole-exome sequencing of 37 patients with AA. Somatic variants were common both in patients and healthy controls but enriched to AA patients' CD8+ T cells, which accumulated most mutations on JAK-STAT and MAPK pathways. Mutation burden was associated with CD8+ T-cell clonality, assessed by T-cell receptor beta sequencing. To understand the effect of mutations, we performed single-cell sequencing of AA patients carrying STAT3 or other mutations in CD8+ T cells. STAT3 mutated clone was cytotoxic, clearly distinguishable from other CD8+ T cells, and attenuated by successful immunosuppressive treatment. Our results suggest that somatic mutations in T cells are common, associate with clonality, and can alter T-cell phenotype, warranting further investigation of their role in the pathogenesis of AA.

摘要

尽管克隆性T细胞扩增很常见,但非白血病性T细胞中体细胞突变的患病率及其功能影响尚未得到充分表征。在免疫介导的再生障碍性贫血(AA)中,细胞毒性T细胞扩增被证明参与疾病发病机制。我们通过一个包含2533个基因的定制面板研究了AA患者T细胞的突变谱。我们对24例AA患者的CD4+和CD8+ T细胞进行了测序,并将结果与20名健康对照以及37例AA患者的全外显子测序结果进行了比较。体细胞变异在患者和健康对照中都很常见,但在AA患者的CD8+ T细胞中更为富集,这些细胞在JAK-STAT和MAPK途径上积累了最多的突变。通过T细胞受体β测序评估,突变负担与CD8+ T细胞克隆性相关。为了解突变的影响,我们对CD8+ T细胞中携带STAT3或其他突变的AA患者进行了单细胞测序。STAT3突变克隆具有细胞毒性,与其他CD8+ T细胞明显不同,并通过成功的免疫抑制治疗而减弱。我们的结果表明,T细胞中的体细胞突变很常见,与克隆性相关,并可改变T细胞表型,需要进一步研究它们在AA发病机制中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc7d/8102188/6930e780a82b/41375_2021_1231_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验